These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23610447)

  • 1. Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.
    Butler EB; Zhao Y; Muñoz-Pinedo C; Lu J; Tan M
    Cancer Res; 2013 May; 73(9):2709-17. PubMed ID: 23610447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SnapShot: Cancer metabolism.
    Brunner JS; Finley LWS
    Mol Cell; 2021 Sep; 81(18):3878-3878.e1. PubMed ID: 34547243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
    Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
    Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic targets of tumor metabolism.
    Kishton RJ; Rathmell JC
    Cancer J; 2015; 21(2):62-9. PubMed ID: 25815845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
    Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
    Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cellular metabolism to improve cancer therapeutics.
    Zhao Y; Butler EB; Tan M
    Cell Death Dis; 2013 Mar; 4(3):e532. PubMed ID: 23470539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis.
    Barger JF; Plas DR
    Endocr Relat Cancer; 2010 Dec; 17(4):R287-304. PubMed ID: 20699334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis.
    Sharma S; Agnihotri N; Kumar S
    Biochem Pharmacol; 2022 Apr; 198():114943. PubMed ID: 35131295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.
    DeBerardinis RJ; Cheng T
    Oncogene; 2010 Jan; 29(3):313-24. PubMed ID: 19881548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer metabolism: a therapeutic window opens.
    Vander Heiden MG
    Nat Rev Drug Discov; 2011 Aug; 10(9):671-84. PubMed ID: 21878982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.
    Luo Z; Xu J; Sun J; Huang H; Zhang Z; Ma W; Wan Z; Liu Y; Pardeshi A; Li S
    Acta Biomater; 2020 Mar; 105():239-252. PubMed ID: 31958597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs link metabolic reprogramming to oncogenesis.
    Hatziapostolou M; Polytarchou C; Iliopoulos D
    Trends Endocrinol Metab; 2013 Jul; 24(7):361-73. PubMed ID: 23602813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors.
    Shan M; Dai D; Vudem A; Varner JD; Stroock AD
    PLoS Comput Biol; 2018 Dec; 14(12):e1006584. PubMed ID: 30532226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Links between cancer metabolism and cisplatin resistance.
    Cocetta V; Ragazzi E; Montopoli M
    Int Rev Cell Mol Biol; 2020; 354():107-164. PubMed ID: 32475471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
    Levine AJ; Puzio-Kuter AM
    Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
    Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
    Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
    Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
    Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered glutamine metabolism and therapeutic opportunities for lung cancer.
    Mohamed A; Deng X; Khuri FR; Owonikoko TK
    Clin Lung Cancer; 2014 Jan; 15(1):7-15. PubMed ID: 24377741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
    Lv J; Wang J; Chang S; Liu M; Pang X
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):17-26. PubMed ID: 26487443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glutamine metabolism on chemoresistance and its mechanism in tumors.
    Hu X; Jin H; Zhu L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):32-40. PubMed ID: 34117847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.